Magnerot (Magnesium Gluconate)

Magnerot is a magnesium supplement indicated for conditions related to low magnesium levels.

• Magnesium deficiency: restores normal serum magnesium concentrations.
• Hypomagnesemia: corrects acute or chronic low magnesium states, supporting neuromuscular and cardiac function.
• Post‑operative electrolyte management: helps maintain electrolyte balance after surgery.

• Magnesium gluconate dissociates to release magnesium ions, which act as essential cofactors for numerous enzymatic reactions, including ATP synthesis and protein phosphorylation. The ions stabilize cell membranes, modulate calcium influx, and support normal neuromuscular transmission and cardiac electrophysiology, thereby correcting magnesium deficits.

Adverse reactions may occur with parenteral magnesium gluconate administration.

Common Side Effects

• Injection site pain: mild to moderate discomfort at the injection site.
• Flushing: transient redness and warmth.
• Hypotension: temporary drop in blood pressure.
• Nausea: mild gastrointestinal upset.
• Dizziness: sensation of light‑headedness.
• Headache: mild to moderate headache.

Serious or Rare Side Effects

• Hypermagnesemia: excessive serum magnesium leading to cardiac arrhythmia.
• Respiratory depression: reduced breathing effort in severe cases.
• Severe allergic reaction: anaphylaxis with rash, swelling, or bronchospasm.
• Cardiac arrest: rare but life‑threatening event.
• Muscle weakness: profound neuromuscular blockade.
• Renal failure exacerbation: worsening kidney function due to reduced magnesium clearance.

Magnerot should be used with attention to patient‑specific factors and proper handling.

• Renal impairment: assess serum magnesium and adjust dose.
• Cardiac disease: monitor ECG and blood pressure during infusion.
• Electrolyte imbalance: correct concurrent calcium or potassium abnormalities.
• Concomitant neuromuscular blockers: avoid potentiation of muscle relaxation.
• Pregnancy and lactation: safety not established; use only if clearly needed.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Magnerot may interact with several medications; awareness of interaction severity guides clinical decisions.

Major Interactions (Avoid)

• Neuromuscular blocking agents: may potentiate muscle relaxation.
• Calcium channel blockers: additive hypotensive effect.
• Quinidine: increased risk of arrhythmia.

Moderate Interactions (Monitor Closely)

• Loop diuretics: enhance renal magnesium loss.
• ACE inhibitors: may alter electrolyte balance.
• Antibiotics (e.g., tetracyclines): potential reduction in absorption when oral forms are used.